Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1989 | 12-1988 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,656 | -954 |
| Depreciation Amortization | 193 | 13 |
| Other Working Capital | -281 | 7 |
| Other Operating Activity | -534 | 0 |
| Operating Cash Flow | $-3,278 | $-934 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -434 | -488 |
| Other Investing Activity | -1,958 | 0 |
| Investing Cash Flow | $-2,392 | $-488 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 10,327 | 6,361 |
| Financing Cash Flow | $10,327 | $6,361 |
| Beginning Cash Position | 4,939 | N/A |
| End Cash Position | 9,595 | 4,939 |
| Net Cash Flow | $4,657 | $4,939 |
| Free Cash Flow | ||
| Operating Cash Flow | -3,278 | -934 |
| Free Cash Flow | -3,278 | -934 |